Xvivo Perfusion AB (publ)
OTC: XVIPY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Christoffer Rosenblad
- Employees
- 170
- Headquarters
- Gothenburg, Sweden
- IPO year
- 2022
- Market cap
- $898.2M
- Website
- https://www.xvivoperfusion.com
Loading XVIPY…
Loading profile data…Frequently asked questions about XVIPY
What does Xvivo Perfusion AB (publ) (XVIPY) do?
Xvivo Perfusion AB (publ), a medical technology enterprise based in Gothenburg, Sweden, specializes in developing cutting-edge solutions for the preservation and perfusion of organs, tissues, and cells, crucial for transplantation. The company's reach spans diverse global markets, including Sweden, the United States, broader North and South Amer...
Where does XVIPY trade?
Xvivo Perfusion AB (publ) (XVIPY) trades on the Other OTC.
What sector is XVIPY in?
Xvivo Perfusion AB (publ) (XVIPY) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Xvivo Perfusion AB (publ)?
Christoffer Rosenblad is the chief executive officer of Xvivo Perfusion AB (publ) (XVIPY).
Where is Xvivo Perfusion AB (publ) headquartered?
Xvivo Perfusion AB (publ) is headquartered in Sweden.
Does XVIPY pay a dividend?
Xvivo Perfusion AB (publ) (XVIPY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XVIPY go public?
Xvivo Perfusion AB (publ) (XVIPY) completed its initial public offering in 2022.
Is XVIPY an ADR?
Yes — XVIPY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Xvivo Perfusion AB (publ) reporting and dividends follow the underlying issuer.